-

United States Peripheral Vascular Devices Market Report 2020-2026 - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report Suite | United States | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering.

One of the greatest limitations in this market is the pricing pressure that is occurring within the office-based lab (OBL) setting. Although these clinics have led to a significant increase in efficiency, reducing the average time for patients to be within a hospital, these settings are also incredibly price sensitive. It is typical that there is a 30% discount on devices sold to an OBL, relative to a hospital.

As more OBLs continue to be developed, and more procedures continue to be shifted towards this setting, there are expected to be price pressures on PTA balloons, stents, atherectomy devices, and associated products for performing routine procedures.

This report on the U.S. market for peripheral vascular devices includes peripheral vascular stents, venous stents, percutaneous transluminal angioplasty (PTA) balloon catheters, drug-coated balloons (DCBs), atherectomy devices, intravascular lithotripsy, chronic total occlusion (CTO) devices, surgical grafts, stent grafts, embolic protection devices (EPDs), peripheral thrombus management devices, inferior vena cava filters (IVCFs) and retrieval devices, carotid shunts, transcarotid arterial revascularization (TCAR) flow reversal systems and stents, diagnostic and interventional catheters, diagnostic and interventional guidewires, introducer sheaths, vascular closure devices (VCDs), transcatheter embolization devices and peripheral IVUS catheters.

Many of these devices can be used for treating either coronary arterial disease or peripheral arterial disease (PAD). However, only devices used for peripheral procedures are included in this report.

Report Coverage

  • U.S. Peripheral Vascular Device Market Overview
  • Competitive Analysis
  • Market Trends
  • Market Developments
  • Procedure Numbers
  • Procedure Codes Investigated
  • Markets Included

Research Methodology

Step 1: Project Initiation & Team Selection

Step 2: Prepare Data Systems and Perform Secondary Research

Step 3: Preparation for Interviews & Questionnaire Design

Step 4: Performing Primary Research

Step 5: Research Analysis: Establishing Baseline Estimates

Step 6: Market Forecast and Analysis

Step 7: Identify Strategic Opportunities

Step 8: Final Review and Market Release

Step 9: Customer Feedback and Market Monitoring

Disease Overview

2.1 Basic Anatomy

2.2 Disease Treatments & Diagnostics

2.2.1 Aortic Aneurysms

2.2.2 Atherosclerosis

2.2.3 Peripheral Arterial Disease (Pad)

2.2.4 Deep Vein Thrombosis (Dvt)

2.2.5 Pulmonary Embolism (Pe)

2.3 Patient Demographics

2.3.1 Aortic Aneurysms

2.3.2 Atherosclerosis

2.3.3 Peripheral Arterial Disease (Pad)

2.3.4 Deep Vein Thrombosis (Dvt)

2.3.5 Pulmonary Embolism (Pe)

Product Assessment

3.1 Introduction

3.2 Product Portfolios

3.2.1 Peripheral Vascular Stent

3.2.2 Venous Stent

3.2.3 Percutaneous Transluminal Angioplasty (Pta) Balloon

3.2.4 Drug-Coated Balloon

3.2.5 Atherectomy Device

3.2.6 Chronic Total Occlusion (Cto) Device

3.2.7 Intravascular Lithotripsy

3.2.8 Surgical Graft

3.2.9 Stent Graft

3.2.10 Embolic Protection Device

3.2.11 Peripheral Thrombus Management Device

3.2.12 Inferior Vena Cava Filter

3.2.13 Carotid Shunt

3.2.14 Diagnostic and Interventional Catheters

3.2.15 Diagnostic and Interventional Guidewire

3.2.16 Introducer Sheath

3.2.17 Vascular Closure Device (Vcd)

3.2.18 Transcatheter Embolization Device

3.2.19 Peripheral Ivus Catheter

3.3 Regulatory Issues and Recalls

3.3.1 Abbott

3.3.1.1 Carotid Shunt

3.3.1.2 Vascular Closure Device

3.3.2 Argon Medical

3.3.2.1 Introducer Sheaths

3.3.3 Arrow International

3.3.3.1 Introducer Sheaths

3.3.4 Atrium Medical

3.3.4.1 Peripheral Vascular Stent

3.3.5 Bd

3.3.5.1 Inferior Vena Cava Filter

3.3.5.2 Introducer Sheaths

3.3.5.3 Stent Graft

3.3.6 Boston Scientific

3.3.6.1 Atherectomy Devices

3.3.6.2 Diagnostic and Interventional Catheters

3.3.6.3 Introducer Sheaths

3.3.6.4 Peripheral Thrombus Management Devices

3.3.7 Cardinal Health

3.3.7.1 Vascular Closure Devices

3.3.8 Cardiovascular System (C.S.I.)

3.3.8.1 Atherectomy Devices

3.3.9 Cook Medical

3.3.9.1 Diagnostic and Interventional Catheters

3.3.9.2 Introducer Sheaths

3.3.9.3 Inferior Vena Cava Filters

3.3.9.4 Peripheral Vascular Stents

3.3.9.5 Stent Grafts

3.3.10 Cordis (Cardinal Health)

3.3.10.1 Diagnostic and Interventional Catheters

3.3.10.2 Inferior Vena Cava Filters

3.3.10.3 Peripheral Stents

3.3.11 Endologix

3.3.11.1 Stent Grafts

3.3.12 Edwards Lifesciences

3.3.12.1 Chronic Total Occlusion Devices

3.3.13 Maquet

3.3.13.1 Pta Balloons

3.3.14 Medtronic

3.3.14.1 Carotid Shunts

3.3.14.2 Diagnostic and Interventional Catheters

3.3.14.3 Pta Balloon Catheters

3.3.14.4 Peripheral Stents

3.3.14.5 Stent Grafts

3.3.14.6 Transcatheter Embolization Devices

3.3.15 Spectranetics (Philips)

3.3.15.1 Atherectomy Devices

3.3.15.2 Chronic Total Occlusion Devices

3.3.16 Shockwave Medical, Inc.

3.3.16.1 Intravascular Lithotripsy

3.3.17 Terumo

3.3.17.1 Introducer Sheaths

3.3.17.2 Pta Balloon Catheters

3.3.18 Other Companies

3.3.18.1 Atherectomy Devices

3.3.18.2 Introducer Sheaths

3.3.18.3 Pta Balloon Catheters

3.3.18.4 Peripheral Ivus Catheters

3.3.18.5 Stent Grafts

3.3.18.6 Vascular Closure Devices (Vcd)

3.4 Clinical Trials

3.4.1 Abbott

3.4.1.1 Peripheral Vascular Stent

3.4.1.2 Other Peripheral Vascular Related Studies

3.4.2 B. Braun

3.4.2.1 Diagnostic and Interventional Catheters

3.4.2.2 Peripheral Vascular Stent

3.4.3 Boston Scientific

3.4.3.1 Atherectomy Devices

3.4.3.2 Drug-Coated Balloons

3.4.3.3 Peripheral Vascular Stents

3.4.3.4 Other Peripheral Vascular Related Studies

3.4.3.5 Venous Stents

3.4.4 C.R. Bard (Bd)

3.4.4.1 Diagnostic and Interventional Catheters

3.4.4.2 Drug-Coated Balloons

3.4.4.3 Venous Stents

3.4.4.4 Other Peripheral Vascular Related Studies

3.4.5 Cardinal Health

3.4.5.1 Other Peripheral Vascular Related Studies

3.4.6 Cook Medical

3.4.6.1 Drug-Eluting Stents

3.4.6.2 Inferior Vena Cava Filters

3.4.6.3 Peripheral Vascular Stents

3.4.6.4 Venous Stents

3.4.7 Cordis (Cardinal Health)

3.4.7.1 Peripheral Vascular Stents

3.4.8 Medtronic

3.4.8.1 Atherectomy Devices

3.4.8.2 Drug-Coated Balloons

3.4.8.3 Other Peripheral Vascular Related Studies

3.4.9 Merit Medical

3.4.9.1 Stent Grafts

3.4.10 Philips/Spectranetics

3.4.10.1 Atherectomy Devices

3.4.10.2 Peripheral Ivus Catheters

3.4.10.3 Spectranetics

3.4.10.3.1 Drug-Coated Balloons

3.4.10.3.2 Atherectomy Devices

3.4.11 Shockwave Medical, Inc.

3.4.11.1 Lithoplasty System

3.4.12 Surmodics

3.4.12.1 Drug-Coated Balloons

3.4.13 Terumo

3.4.13.1 Drug-Coated Balloons

3.4.13.2 Peripheral Vascular Stents

3.4.14 W.L. Gore

3.4.14.1 Peripheral Vascular Stents

3.4.14.2 Stent Grafts

3.4.14.3 Expandable Balloons

3.4.15 Other Companies

3.4.15.1 Carotid Shunt / Endarterectomy

3.4.15.2 Drug-Coated Balloons

3.4.15.3 Peripheral Vascular Stents

3.4.15.4 Other Peripheral Vascular Related Studies

U.S. Peripheral Vascular Device Market Overview

4.1 Introduction

4.1.1 Atherosclerosis

4.1.2 Peripheral Arterial Disease (Pad)

4.2 Market Overview

4.3 Trend Analysis by Segment

4.4 Drivers and Limiters

4.4.1 Market Drivers

4.4.2 Market Limiters

4.5 Competitive Market Share Analysis

4.6 Mergers and Acquisitions

4.7 Company Profiles

4.7.1 Abbott

4.7.2 Becton Dickinson (Bd)

4.7.3 Boston Scientific

4.7.4 Cardinal Health

4.7.4.1 Cordis (Cardinal Health)

4.7.5 Cook Medical

4.7.6 Maquet

4.7.7 Medtronic

4.7.8 Teleflex

4.7.9 Terumo Interventional System (Tis)

4.7.10 W.L. Gore

4.8 SWOT Analysis

4.8.1 Abbott

4.8.2 B. Braun

4.8.3 Boston Scientific

4.8.4 Bd

4.8.5 Cardinal Health

4.8.6 Cook Medical

4.8.7 Integra Lifesciences

4.8.8 Maquet

4.8.9 Medtronic

4.8.10 Merit Medical

4.8.11 Phillips

4.8.12 Teleflex

4.8.13 Terumo

4.8.14 W.L. Gore

Procedure Numbers

5.1 Introduction

5.2 Procedures

5.2.1 Total Peripheral Vascular Procedures

5.2.2 Total Peripheral Vascular Procedures by Device Type, Indication, Intervention & Care Setting

5.2.2.1 Above-The-Knee Procedures

5.2.2.1.1 Above-The-Knee Stent Procedures

5.2.2.1.2 Above-The-Knee Poba Procedures by Care Setting

5.2.2.1.3 Above-The-Knee Dcb Procedures by Care Setting

5.2.2.1.4 Above-The-Knee Atherectomy Without Stent Procedures by Care Setting

5.2.2.1.5 Above-The-Knee Atherectomy With Stent Procedures by Care Setting

5.2.2.2 Below-The-Knee Procedures

5.2.2.2.1 Below-The-Knee Stent Procedures by Device Type

5.2.2.2.2 Below-The-Knee Stent Procedures by Care Setting

5.2.2.2.3 Below-The-Knee Poba Procedures by Care Setting

5.2.2.2.4 Below-The-Knee Dcb Procedures by Care Setting

5.2.2.2.5 Below-The-Knee Atherectomy Without Stent Procedures by Care Setting

5.2.2.2.6 Below-The-Knee Atherectomy With Stent Procedures by Care Setting

5.2.2.3 Iliac Procedures

5.2.2.3.1 Iliac Stent Procedures by Device Type

5.2.2.3.2 Iliac Stent Procedures by Care Setting

5.2.2.3.3 Iliac Poba Procedures by Care Setting

5.2.2.4 Av Access Procedures

5.2.2.4.1 Av Access Covered Stent Procedures by Care Setting

5.2.2.4.2 Av Access Poba Procedures by Care Setting

5.2.2.4.3 Av Access Dcb Procedures by Care Setting

5.2.2.5 Renal Procedures

5.2.2.6 Carotid Procedures

5.2.3 Peripheral Vascular Stent Procedures

5.2.3.1 Peripheral Arterial Stent Procedures by Stent Type

5.2.3.1.1 Bare-Metal Stent Procedures

5.2.3.1.2 Covered Stent Procedures

5.2.3.1.3 Drug-Eluting Stent Procedures

5.2.4 Peripheral Venous Stent

5.2.5 Pta Balloon Catheter Procedures

5.2.6 Drug-Coated Balloon Procedures

5.2.6.1 Drug-Coated Balloon Procedures by Indication

5.2.7 Atherectomy Procedures

5.2.7.1 Atherectomy Procedures by Device Type

Companies Mentioned (A-Z)

  • Abbott
  • Argon Medical
  • Arrow International
  • Atrium Medical
  • B. Braun
  • Becton Dickinson (BD)
  • Boston Scientific
  • C.R. Bard (BD)
  • Cardinal Health
  • Cardiovascular System (C.S.I.)
  • Cook Medical
  • Cordis (Cardinal Health)
  • Edwards Lifesciences
  • Endologix
  • Integra Lifesciences
  • Maquet
  • Medline
  • Medtronic
  • Merit Medical
  • Mermaid Medical
  • Micro Medical Solutions
  • Morris Innovative Inc.
  • Nipro
  • NuCryo Vascular
  • Oscor
  • Penumbra
  • Pfizer
  • PFM Medical
  • Philips/Spectranetics
  • Phillips
  • Provisio Medical
  • RA Medical
  • Radius Medical
  • Reflow Medical
  • Rex Medical
  • Roxwood Medical
  • Shockwave Medical, Inc.
  • Silk Road Medical
  • Sirtex
  • Spectranetics (Philips)
  • Surmodics
  • Teleflex Medical
  • Terumo Interventional System (TIS)
  • Theragenics/Galt
  • Tricol Biomedical
  • TriReme Medical
  • TZ Medical
  • Varian Medical Systems
  • Vascular Flow Technologies
  • W. L. Gore

For more information about this report visit https://www.researchandmarkets.com/r/x7wpgk

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Research and Markets


Release Versions

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

More News From Research and Markets

AtriCure Inc (ATRC) Product Pipeline Analysis Report 2025: Portfolio Led by Isolator Synergy, AtriClip, Hybrid AF Therapy, and cryoICE cryoSPHERE Technologies - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "AtriCure Inc (ATRC) - Product Pipeline Analysis, 2025 Update" company profile has been added to ResearchAndMarkets.com's offering. This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. AtriCure Inc (AtriCure) is a company specialising in the development and provision of medical technologies for the treatment of atr...

Conductive Polymers Market Research Report 2025, Profiles of Major Players - SABIC, Heraeus Group, DuPont, Covestro and Celanese - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Conductive Polymers Market" report has been added to ResearchAndMarkets.com's offering. The global market for conductive polymers is estimated to grow from $11.2 billion in 2025 and forecast to reach $17 billion by 2030, at a compound annual growth rate (CAGR) of 8.6% from 2025 through 2030. The conductive polymers market is undergoing an expansion phase, propelled by the convergence of advanced electronics demands, sustainable energy transitions and environmental,...

Gas and Steam Turbine Global Markets Report 2025-2030: Micro Steam Turbines, Ammonia-Fueled Systems, and Advanced Turbine Innovations Gain Momentum - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Gas and Steam Turbine: Global Markets" report has been added to ResearchAndMarkets.com's offering. The Gas and Steam Turbine Market was valued at USD 31 Billion in 2025, and is projected to reach USD 37.5 Billion by 2030, rising at a CAGR of 3.4%. This report analyzes the global market for gas and steam turbines by technology, capacity and end user for the gas turbines market and by cycle, capacity and sector for the steam turbines market. The report examines the t...
Back to Newsroom